121 related articles for article (PubMed ID: 11101147)
21. Human RPE expression of cell survival factors.
Yang P; Wiser JL; Peairs JJ; Ebright JN; Zavodni ZJ; Bowes Rickman C; Jaffe GJ
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1755-64. PubMed ID: 15851579
[TBL] [Abstract][Full Text] [Related]
22. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression.
Kinoshita H; Yoshikawa H; Shiiki K; Hamada Y; Nakajima Y; Tasaka K
Int J Cancer; 2000 Dec; 88(6):986-91. PubMed ID: 11093825
[TBL] [Abstract][Full Text] [Related]
24. Activation of caspase-8 is critical for sensitivity to cytotoxic anti-Fas antibody-induced apoptosis in human ovarian cancer cells.
Hayakawa A; Wu J; Kawamoto Y; Zhou YW; Tanuma S; Nakashima I; Suzuki H
Apoptosis; 2002 Apr; 7(2):107-13. PubMed ID: 11865194
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2, Bcl-xL and c-FLIP(L) potentially regulate the susceptibility of human peripheral blood monocyte-derived dendritic cells to cell death at different developmental stages.
Hasebe H; Sato K; Yanagie H; Takeda Y; Nonaka Y; Takahashi TA; Eriguchi M; Nagawa H
Biomed Pharmacother; 2002 May; 56(3):144-51. PubMed ID: 12046686
[TBL] [Abstract][Full Text] [Related]
26. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis.
Perlman H; Pagliari LJ; Georganas C; Mano T; Walsh K; Pope RM
J Exp Med; 1999 Dec; 190(11):1679-88. PubMed ID: 10587358
[TBL] [Abstract][Full Text] [Related]
27. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
Egle A; Villunger A; Marschitz I; Kos M; Hittmair A; Lukas P; Grünewald K; Greil R
Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609
[TBL] [Abstract][Full Text] [Related]
28. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L).
Lundqvist A; Nagata T; Kiessling R; Pisa P
Cancer Immunol Immunother; 2002 May; 51(3):139-44. PubMed ID: 11941452
[TBL] [Abstract][Full Text] [Related]
29. Responding naive T cells differ in their sensitivity to Fas engagement: early death of many T cells is compensated by costimulation of surviving T cells.
Maksimow M; Santanen M; Jalkanen S; Hänninen A
Blood; 2003 May; 101(10):4022-8. PubMed ID: 12531803
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells.
Oshiro MM; Landowski TH; Catlett-Falcone R; Hazlehurst LA; Huang M; Jove R; Dalton WS
Clin Cancer Res; 2001 Dec; 7(12):4262-71. PubMed ID: 11751528
[TBL] [Abstract][Full Text] [Related]
31. Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL.
Fandy TE; Ross DD; Gore SD; Srivastava RK
Cancer Chemother Pharmacol; 2007 Aug; 60(3):313-9. PubMed ID: 17187253
[TBL] [Abstract][Full Text] [Related]
32. c-FLIP-L recombinant adeno-associated virus vector infection prevents Fas-mediated but not nerve growth factor withdrawal-mediated cell death in PC12 cells.
Wu S; Zhou L; Rose M; Xiao X; Graham SH
Brain Res Mol Brain Res; 2004 Mar; 122(1):79-87. PubMed ID: 14992818
[TBL] [Abstract][Full Text] [Related]
33. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation.
Hatano E; Brenner DA
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740
[TBL] [Abstract][Full Text] [Related]
34. Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines.
Spets H; Georgii-Hemming P; Siljason J; Nilsson K; Jernberg-Wiklund H
Blood; 1998 Oct; 92(8):2914-23. PubMed ID: 9763578
[TBL] [Abstract][Full Text] [Related]
35. Intracellular regulation of Fas-induced apoptosis in human fibroblasts by extracellular factors and cycloheximide.
Santiago B; Galindo M; Palao G; Pablos JL
J Immunol; 2004 Jan; 172(1):560-6. PubMed ID: 14688367
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
Arthritis Rheum; 2000 May; 43(5):1106-14. PubMed ID: 10817565
[TBL] [Abstract][Full Text] [Related]
37. NF-kappa B is required for surface Ig-induced Fas resistance in B cells.
Schram BR; Rothstein TL
J Immunol; 2003 Mar; 170(6):3118-24. PubMed ID: 12626568
[TBL] [Abstract][Full Text] [Related]
38. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
39. The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis.
Haux J; Johnsen AC; Steinkjer B; Egeberg K; Sundan A; Espevik T
Cancer Immunol Immunother; 1999; 48(2-3):139-46. PubMed ID: 10414468
[TBL] [Abstract][Full Text] [Related]
40. Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide.
Tu Y; Xu FH; Liu J; Vescio R; Berenson J; Fady C; Lichtenstein A
Blood; 1996 Sep; 88(5):1805-12. PubMed ID: 8781438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
